Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities
- 2 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Heart and Vessels
- Vol. 36 (9), 1350-1358
- https://doi.org/10.1007/s00380-021-01813-2
Abstract
The Academic Research Consortium (ARC) recently published a definition of patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention. However, the prevalence of the ARC-HBR criteria in patients undergoing endovascular therapy (EVT) for peripheral artery disease in lower extremities has not been thoroughly investigated. This study sought to investigate the prevalence and impact of the ARC-HBR criteria in patients undergoing EVT. We analyzed 277 consecutive patients who underwent their first EVT from July 2011 to September 2019. We applied the full ARC-HBR criteria to the study population. The primary end point was a composite outcome of all-cause mortality, Bleeding Academic Research Consortium 3 or 5 bleeding, and lower limb amputation within 12 months of EVT. Among the 277 patients, 193 (69.7%) met the ARC-HBR criteria. HBR patients had worse clinical outcomes compared with non-HBR patients at 12 months after EVT, including a higher incidence of the composite primary outcome (19.2% vs. 3.6%, p < 0.001) and all-cause death (7.8% vs. 0%, p = 0.007). In a multivariate Cox proportional hazards regression analysis, presence of the ARC-HBR criteria [hazard ratio (HR) 4.15, 95% confidence interval (CI) 1.25–13.80, p = 0.020], body mass index (HR 1.13, 95% CI 1.01–1.27, p = 0.042), diabetes mellitus (HR 2.70, 95% CI 1.28–5.69, p = 0.009), hyperlipidemia (HR 0.41, 95% CI 0.21–0.80, p = 0.009), and infrapopliteal lesions (HR 3.51, 95% CI 1.63–7.56, p = 0.001) were independent predictors of the primary composite outcome. Approximately 70% of Japanese patients undergoing EVT met the ARC-HBR criteria, and its presence was strongly associated with adverse outcomes within 12 months of EVT.Keywords
This publication has 35 references indexed in Scilit:
- High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registryEuroIntervention, 2021
- Prevalence of the Academic Research Consortium for High Bleeding Risk Criteria and Prognostic Value of a Simplified DefinitionCirculation Journal, 2020
- Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI PatientsJournal of the American College of Cardiology, 2020
- Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding RiskCirculation, 2020
- Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2019
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary InterventionCirculation, 2019
- Incidence and predictors of bleeding complications after percutaneous coronary interventionJournal of Cardiology, 2016
- Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2015
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Incidence, Predictors, and Prognostic Implications of Hospitalization for Late Bleeding After Percutaneous Coronary Intervention for Patients Older Than 65 YearsCirculation: Cardiovascular Interventions, 2010